Program Overview
The 2025 New York Transcatheter Valves Symposium will take place on Thursday, December 11, 2025, at The Mount Sinai Hospital’s Stern Auditorium in New York, NY. This year’s course is designed to equip healthcare professionals with the latest insights into the evolving landscape of valvular and structural heart disease.
Attendees will benefit from a comprehensive, expert-led agenda featuring didactic lectures, live case transmissions of transcatheter procedures, and engaging panel discussions with renowned leaders in the field. With interactive Q&A sessions and real-time case demonstrations, the program offers a unique platform to explore cutting-edge innovations, techniques, and controversies in structural heart interventions.
Whether you’re looking to enhance your clinical knowledge, refine procedural decision-making, or engage with peers at the forefront of the field, this symposium offers invaluable learning in a dynamic, real-world setting.
Learning Objectives
- Identify the barriers to care for patients with valvular heart disease, with a focus on addressing current gaps in the timely delivery of percutaneous and surgical interventions.
- Discuss the indications, techniques, outcomes, and potential complications for transcatheter valve interventions in patients with native valve disease and bioprosthetic valve dysfunction.
- Analyze the rationale, challenges, and importance of the heart team approach to valvular heart disease, including the appropriate selection of cases for structural heart intervention.
- Examine the latest and emerging technologies in the management of structural heart disease to evaluate their benefits for patient care.
Target Audience
The New York Valves Symposium has been designed to meet the educational needs of interventional cardiologists, non-invasive cardiologists, cardiothoracic surgeons, heart failure specialists, interventional and imaging fellows-in-training, nurses, technicians and advanced practice professionals who work in structural heart disease.
